Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXP8JO
|
||||
| Drug Name |
N3-(4-(1-methylpiperidin-4-yl)phenyl)-1-(pyridin-2-yl)-1H-1,2,4-triazole-3,5-diamine
|
||||
| Synonyms |
CHEMBL1835867
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H23N7
|
||||
| Canonical SMILES |
CN1CCC(CC1)c2ccc(Nc3nc(N)n(n3)c4ccccn4)cc2
|
||||
| InChI |
InChI=1S/C19H23N7/c1-25-12-9-15(10-13-25)14-5-7-16(8-6-14)22-19-23-18(20)26(24-19)17-4-2-3-11-21-17/h2-8,11,15H,9-10,12-13H2,1H3,(H3,20,22,23,24)
|
||||
| InChIKey |
JBBBYMPMAJVCSI-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | FL cytokine receptor | Target Info | [1587926] | ||
| Mast/stem cell growth factor receptor | Target Info | [1587926] | |||
| KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
| Hematopoietic cell lineage | |||||
| Pathways in cancer | |||||
| Transcriptional misregulation in cancer | |||||
| Acute myeloid leukemia | |||||
| Central carbon metabolism in cancerhsa04014:Ras signaling pathway | |||||
| Rap1 signaling pathway | |||||
| Endocytosis | |||||
| PI3K-Akt signaling pathway | |||||
| Melanogenesis | |||||
| Central carbon metabolism in cancer | |||||
| Pathway Interaction Database | C-MYB transcription factor network | ||||
| Signaling events mediated by Stem cell factor receptor (c-Kit) | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.